These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22074933)

  • 1. Susceptibility to varicella-zoster among pregnant women in the province of Lecce, Italy.
    Guido M; Tinelli A; De Donno A; Quattrocchi M; Malvasi A; Campilongo F; Zizza A;
    J Clin Virol; 2012 Jan; 53(1):72-6. PubMed ID: 22074933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-varicella antibody in young women before their marriage: A sero-epidemiologic study in Iran.
    Pourahmad M; Davami MH; Jahromi AR
    J Clin Virol; 2010 Aug; 48(4):260-3. PubMed ID: 20538515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
    Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
    Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
    Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
    Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history.
    Fung LW; Lao TT; Suen SS; Chan OK; Lau TK; Ngai KL; Chan PK; Leung TY
    Vaccine; 2011 Oct; 29(46):8186-8. PubMed ID: 21911021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
    Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
    Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incorporation of varicella-zoster virus vaccination in childhood immunization schedules].
    Rothbart H; Rishpon S
    Harefuah; 2008; 147(8-9):693-7, 751, 750. PubMed ID: 18935757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing.
    Vilibic-Cavlek T; Ljubin-Sternak S; Kolaric B; Kaic B; Sviben M; Kos L; Mlinaric-Galinovic G
    Arch Gynecol Obstet; 2012 Oct; 286(4):901-4. PubMed ID: 22678561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
    N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.